Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PFE crawled date : 2021 - 09 - 24 save search
Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency
Published: 2021-09-24 (Crawled : 21:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
| Email alert
Add to watchlist
OPK | $1.225 -2.0% -2.04% 6.1M
|
Health Technology
| Email alert
Add to watchlist
fda growth hormone license growth hormone application
Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206
Published: 2021-09-24 (Crawled : 06:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
new drug china drug approval application
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.